AI Agents for B2B Productivity: Anthropic's 2026 Vision
Learn about the impact of AI agents on B2B productivity in 2026. This analysis details enterprise adoption trends, case studies, and Anthropic's technical visio
Back to Articles
Articles tagged with “anthropic”
B2B AI Agents: Productivity Gains & Anthropic's Approach
Explore the state of AI agents for B2B productivity. This 2026 analysis covers agentic AI, enterprise adoption, economic impact, and Anthropic's solutions.
Andon Labs' Project Vend: Testing Autonomous AI Agents
Explore Andon Labs' profile and its Project Vend collaboration with Anthropic. Learn how autonomous AI agents using LLMs are benchmarked for business tasks.
Claude Code in Life Sciences: Practical Applications Guide
Explore practical applications of Claude Code in life sciences. This guide covers its use in genomics, bioinformatics, and R&D automation via tool connectors. L
Claude Skills vs. MCP: A Technical Comparison for AI Workflows
Learn the key differences between Anthropic's Claude Skills and the Model Context Protocol (MCP). This guide explains their architecture and use cases.
Claude Sonnet 4.5: Model Upgrades & Code 2.0 Features
An overview of Anthropic's Claude Sonnet 4.5 model, its performance benchmarks, Claude Code 2.0 features like checkpoints, subagents, hooks, and IDE integration, plus updates on Opus 4.6 agent teams
Integrating MCP Servers for Web Search with Claude Code
A comprehensive guide to MCP servers for Claude Code web search, including Brave Search, Perplexity Sonar, Bright Data, and Firecrawl. Updated for 2026 with MCP Tool Search, OAuth authentication, and managed configuration.
Anthropic Claude 4: Evolution of a Large Language Model
Explore the history and development of Anthropic's Claude 4 large language model, covering its evolution to Claude 4.5, key features, benchmarks, and advancements through January 2026.
Dario Amodei, Demis Hassabis & Jensen Huang: Compressing a Century of Biology into a Decade
How AI leaders like Amodei, Hassabis, and Huang are accelerating drug discovery, genomics, and life science breakthroughs—compressing decades into years. Updated January 2026 with AlphaFold 3, Claude for Life Sciences, NVIDIA Evo 2, and $3B+ pharma partnerships.